Vicki Moore, PhD

Comprehensive geriatric assessment was shown to effectively identify vulnerability to AEs in patients with HNC across all ages.

Relative survival rates were found to improve for all patient age groups over time, although excess mortality persisted to some degree.

All patients in this study reported positive behavioral change as much as 4.5 years after treatment with a single dose of psilocybin.

Workplace accommodations are significant factors in cancer survivors’ ability to return to work and still be working at 5 years postdiagnosis.

Mutations were found in 70% of patients, with 53% of patients possessing driver mutations and 17 genes showing mutations in more than 2% of patients.

The positive influence of nurse navigation program on CRC screenings rates and barriers was demonstrated by a team of researchers in Turkey.

This cross-sectional study investigated the prevalence and severity of cough among patients with lung cancer who are undergoing treatment for their cancer, and compared these results with that of patients with lung cancer who are not undergoing treatment.

Researchers compared the monoclonal immunoglobulin rapid accurate measurement and matrix-assisted laser desorption/ionization-time of flight assays.

An analysis of results from 3 clinical trials demonstrated that pegaspargase is cost-effective, improved quality-adjusted life-years, and was the dominant therapy in comparisons with native asparagine in multiple scenarios.

Researchers suggested several criteria for determining drug value in a survey given to participants for feedback.